Article
2011 AAN Pre-conference Coverage: Biomarkers for Diagnosing Alzheimer's
Dr. Jeffrey Burns previews what he will be discussing about Alzheimer's disease at the upcoming American Academy of Neurology Annual Meeting.
Jeffrey Burns, MD, director, Alzheimer and Memory Program, University of Kansas Medical Center, reviews the latest advances in the development and use of biomarkers in diagnosing Alzheimer’s disease. He discusses the focus on biomarkers in the latest revisions to the Alzheimer’s disease diagnostic criteria, the emerging roles of imaging and spinal fluid biomarkers, and the significant role that biomarkers can play in confirming a diagnosis.
(depending on bandwith, the below audio player may take a minute or two to load and appear on your screen)
Real-World Study Confirms Similar Efficacy of Guselkumab and IL-17i for PsA
